Drug
Dexamethasone
Dexamethasone: highest development phase Approved, developed by AbbVie, GlaxoSmithKline, Immunocore and others. 5 trial records tracked on RxWires.
- Highest phase
- Approved
- Developer
- AbbVie, GlaxoSmithKline, Immunocore
Trials
| Drug | Phase | Indication |
|---|---|---|
| DEXAMETHASONE SODIUM PHOSPHATE | Approved | |
| Dexamethasone NCT00891761 | Phase 3 | Cancer |
| Dexamethasone NCT07803562 | Phase 2 | Uveal Melanoma, Metastatic |
| Dexamethasone NCT03314181 | Phase 2 | Multiple Myeloma |
| Dexamethasone NCT05848687 | Phase 1/2 | Lymphoblastic Leukemia |
Latest
Follow Dexamethasone on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.